首页 > 最新文献

Uirusu最新文献

英文 中文
[Development and Implementation of HPV Vaccination]. [发展和实施HPV疫苗接种]。
Pub Date : 2024-01-01 DOI: 10.2222/jsv.74.9
Nagayasu Egawa

Cervical cancer is primarily caused by infection with the human papillomavirus (HPV) and has become a disease that can be effectively prevented through vaccination and cervical screening. This review briefly summarises the virological background, development process, and actual implementation of HPV prophylactic vaccines, which are a key pillar of prevention. With prophylactic HPV vaccination and cervical screening, the incidence of HPV-related cancers is expected to decrease significantly. The ultimate goal is to achieve a society with "One Less Worry" about HPV infections and the cancers they cause.

子宫颈癌主要由人乳头瘤病毒(HPV)感染引起,现已成为一种可通过接种疫苗和子宫颈普查有效预防的疾病。本文简要综述了HPV预防疫苗的病毒学背景、发展过程和实际实施情况,这是预防的关键支柱。通过预防性HPV疫苗接种和子宫颈筛查,HPV相关癌症的发病率预计会显著下降。最终目标是实现一个对HPV感染及其引起的癌症“少担心”的社会。
{"title":"[Development and Implementation of HPV Vaccination].","authors":"Nagayasu Egawa","doi":"10.2222/jsv.74.9","DOIUrl":"https://doi.org/10.2222/jsv.74.9","url":null,"abstract":"<p><p>Cervical cancer is primarily caused by infection with the human papillomavirus (HPV) and has become a disease that can be effectively prevented through vaccination and cervical screening. This review briefly summarises the virological background, development process, and actual implementation of HPV prophylactic vaccines, which are a key pillar of prevention. With prophylactic HPV vaccination and cervical screening, the incidence of HPV-related cancers is expected to decrease significantly. The ultimate goal is to achieve a society with \"One Less Worry\" about HPV infections and the cancers they cause.</p>","PeriodicalId":75275,"journal":{"name":"Uirusu","volume":"74 1","pages":"9-16"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142775472","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Elucidation of the molecular basis of negative-strand RNA virus genome replication]. [负链RNA病毒基因组复制分子基础的阐明]。
Pub Date : 2024-01-01 DOI: 10.2222/jsv.74.67
Yusuke Matsumoto

The negative-strand RNA viruses are a group that includes many important pathogens. They share the common mechanism of genome replication and mRNA transcription. The viruses possess multifunctional RNA-dependent RNA polymerase that is responsible for all RNA synthesis activity, and the genome RNA is entirely covered with viral nucleoprotein. We aimed to understand these viruses in general by identifying the similarities and differences among each virus group. The viruses belonging to the family Paramyxoviridae in the order Mononegavirales is known to follow the "Rule of Six", which states that the number of nucleotides in the genome must be a multiple of six to be replicated. We have succeeded in generating a paramyxovirus that does not follow the Rule of Six and challenged to elucidate the significance of the Rule of Six using this recombinant virus. We also performed functional analysis of the promoter structure at the end of the genome of the viruses belonging to the order Bunyavirales and revealed unique features of RNA synthesis that differ from other segmented RNA viruses in the family Nairoviridae. Furthermore, we elucidated the unique mechanism of the Borna disease virus to establish persistent infection in the nucleus that is an exceptional property among RNA viruses.

负链RNA病毒是一类包括许多重要病原体的病毒。它们具有共同的基因组复制和mRNA转录机制。病毒具有多功能RNA依赖RNA聚合酶,负责所有RNA合成活性,基因组RNA完全被病毒核蛋白覆盖。我们的目标是通过识别每个病毒组之间的异同来了解这些病毒。已知这种病毒属于单病毒目副粘病毒科,遵循“六法则”,即基因组中核苷酸的数量必须是六的倍数才能复制。我们已经成功地产生了一种不遵循六法则的副粘病毒,并挑战着用这种重组病毒来阐明六法则的意义。我们还对该病毒基因组末端的启动子结构进行了功能分析,揭示了其RNA合成的独特特征,不同于其他奈罗病毒科的分段RNA病毒。此外,我们阐明了博纳病病毒在细胞核中建立持续感染的独特机制,这是RNA病毒的特殊特性。
{"title":"[Elucidation of the molecular basis of negative-strand RNA virus genome replication].","authors":"Yusuke Matsumoto","doi":"10.2222/jsv.74.67","DOIUrl":"https://doi.org/10.2222/jsv.74.67","url":null,"abstract":"<p><p>The negative-strand RNA viruses are a group that includes many important pathogens. They share the common mechanism of genome replication and mRNA transcription. The viruses possess multifunctional RNA-dependent RNA polymerase that is responsible for all RNA synthesis activity, and the genome RNA is entirely covered with viral nucleoprotein. We aimed to understand these viruses in general by identifying the similarities and differences among each virus group. The viruses belonging to the family Paramyxoviridae in the order Mononegavirales is known to follow the \"Rule of Six\", which states that the number of nucleotides in the genome must be a multiple of six to be replicated. We have succeeded in generating a paramyxovirus that does not follow the Rule of Six and challenged to elucidate the significance of the Rule of Six using this recombinant virus. We also performed functional analysis of the promoter structure at the end of the genome of the viruses belonging to the order Bunyavirales and revealed unique features of RNA synthesis that differ from other segmented RNA viruses in the family Nairoviridae. Furthermore, we elucidated the unique mechanism of the Borna disease virus to establish persistent infection in the nucleus that is an exceptional property among RNA viruses.</p>","PeriodicalId":75275,"journal":{"name":"Uirusu","volume":"74 1","pages":"67-76"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142775505","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[HPV vaccinations and cervical cancer in Japan: Flaws in alleged experimental evidence for molecular mimicry and animal models of HPV vaccine-induced "adverse reactions "]. [日本的HPV疫苗接种和宫颈癌:HPV疫苗诱导的“不良反应”的分子模拟和动物模型的所谓实验证据的缺陷]。
Pub Date : 2024-01-01 DOI: 10.2222/jsv.74.17
Reona Shiro, Ikuo Tsunoda

In Japan, around 3,000 females have died of cervical cancer annually. Cervical cancer is caused by sexually transmitted infections of the human papillomavirus (HPV); it is preventable by vaccinations against oncogenic HPV types, such as types 16 and 18. In Japan, the proactive recommendations for HPV vaccinations were suspended in June 2013 due to public concerns about neuropsychological "diverse symptoms" following HPV vaccinations. The suspension resulted in the vaccination rate less than 1% among the eligible population. In April 2022, the Japanese government resumed the proactive HPV vaccination recommendations after 9 years of the suspension. Many Japanese people, however, still have concerns about the "diverse symptoms" as adverse reactions following HPV vaccinations. In this article, we critically evaluated the manuscripts cited in the HPV vaccine lawsuits in Japan, including computational and animal studies, which have been used as the theoretical basis for how HPV vaccinations could induce the "diverse symptoms." We concluded that all the manuscripts had scientific flaws, which should not be used to prove that HPV vaccinations could induce the adverse reactions. We wish that our current evaluation would contribute to eliminating baseless concerns about HPV vaccines, eventually increasing the rate of HPV vaccinations in Japan.

在日本,每年约有3000名女性死于宫颈癌。宫颈癌是由人类乳头瘤病毒(HPV)的性传播感染引起的;它可以通过接种疫苗预防致癌型HPV,如16型和18型。在日本,由于公众对HPV疫苗接种后神经心理“多种症状”的担忧,2013年6月暂停了对HPV疫苗接种的积极建议。暂停疫苗接种导致符合条件人群的疫苗接种率不到1%。2022年4月,日本政府在暂停9年后恢复了主动接种HPV疫苗的建议。然而,许多日本人仍然担心HPV疫苗接种后的“多种症状”作为不良反应。在这篇文章中,我们批判性地评估了日本HPV疫苗诉讼中引用的手稿,包括计算和动物研究,这些研究已被用作HPV疫苗接种如何诱导“多种症状”的理论基础。我们的结论是,所有的手稿都有科学缺陷,不应该用来证明HPV疫苗接种会引起不良反应。我们希望我们目前的评估将有助于消除对HPV疫苗的毫无根据的担忧,最终提高日本的HPV疫苗接种率。
{"title":"[HPV vaccinations and cervical cancer in Japan: Flaws in alleged experimental evidence for molecular mimicry and animal models of HPV vaccine-induced \"adverse reactions \"].","authors":"Reona Shiro, Ikuo Tsunoda","doi":"10.2222/jsv.74.17","DOIUrl":"10.2222/jsv.74.17","url":null,"abstract":"<p><p>In Japan, around 3,000 females have died of cervical cancer annually. Cervical cancer is caused by sexually transmitted infections of the human papillomavirus (HPV); it is preventable by vaccinations against oncogenic HPV types, such as types 16 and 18. In Japan, the proactive recommendations for HPV vaccinations were suspended in June 2013 due to public concerns about neuropsychological \"diverse symptoms\" following HPV vaccinations. The suspension resulted in the vaccination rate less than 1% among the eligible population. In April 2022, the Japanese government resumed the proactive HPV vaccination recommendations after 9 years of the suspension. Many Japanese people, however, still have concerns about the \"diverse symptoms\" as adverse reactions following HPV vaccinations. In this article, we critically evaluated the manuscripts cited in the HPV vaccine lawsuits in Japan, including computational and animal studies, which have been used as the theoretical basis for how HPV vaccinations could induce the \"diverse symptoms.\" We concluded that all the manuscripts had scientific flaws, which should not be used to prove that HPV vaccinations could induce the adverse reactions. We wish that our current evaluation would contribute to eliminating baseless concerns about HPV vaccines, eventually increasing the rate of HPV vaccinations in Japan.</p>","PeriodicalId":75275,"journal":{"name":"Uirusu","volume":"74 1","pages":"17-28"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142775507","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Characterization of SARS-CoV-2 variants using mini-gut organoids]. [使用微型肠道类器官表征SARS-CoV-2变体]。
Pub Date : 2024-01-01 DOI: 10.2222/jsv.74.45
Kei Miyakawa
{"title":"[Characterization of SARS-CoV-2 variants using mini-gut organoids].","authors":"Kei Miyakawa","doi":"10.2222/jsv.74.45","DOIUrl":"https://doi.org/10.2222/jsv.74.45","url":null,"abstract":"","PeriodicalId":75275,"journal":{"name":"Uirusu","volume":"74 1","pages":"45-48"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142775414","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Current situations and future issues surrounding rabies in Japan and other countries]. [日本和其他国家狂犬病的现状和未来问题]。
Pub Date : 2024-01-01 DOI: 10.2222/jsv.74.1
Naoto Ito, Akira Nishizono

Rabies is a viral infectious disease affecting the central nervous system that is generally transmitted from mammals such as dogs. This disease is characterized by a long incubation period (a few months on average) and a high mortality rate of almost 100%. While there are highly effective rabies vaccines, no reliable treatment has been established to date. In Japan, the disease was successfully eradicated in 1957 as a result of exhaustive control measures including vaccination of dogs in accordance with the Rabies Prevention Law. Since then, Japan has continued to take rabies control measures based on this law, which are stricter than international standards. On the other hand, there have been a total of four imported human rabies cases found in Japan. The fourth imported case confirmed in Toyohashi City in May 2020 is still fresh in our minds. In April 2022, special measures were taken to quarantine dogs brought by evacuees from Ukraine to Japan, and many people expressed concern about the introduction of rabies into Japan. More recently, in February 2024, a dog that bit several people in Gunma Prefecture did not receive the shots required by the Rabies Prevention Law, and there was strong concern about rabies and the risk of its occurrence. In this article, we focus on rabies, which has recently attracted a great deal of attention, and describe the nature of this infectious disease. We also outline the current situations of rabies control and medical care in Japan and other countries and discuss the future issues.

狂犬病是一种影响中枢神经系统的病毒性传染病,通常由狗等哺乳动物传播。这种疾病的特点是潜伏期长(平均几个月),死亡率高,几乎为100%。虽然有非常有效的狂犬病疫苗,但迄今为止还没有确定可靠的治疗方法。在日本,由于采取了彻底的控制措施,包括根据《狂犬病防治法》给狗接种疫苗,这种疾病于1957年成功根除。此后,日本一直根据该法律采取比国际标准更严格的狂犬病控制措施。另一方面,日本共发现四宗输入性人类狂犬病个案。2020年5月在丰桥市确诊的第四例输入性病例仍然历历在目。2022年4月,日本采取了特别措施,对从乌克兰撤离到日本的人带来的狗进行检疫,许多人对狂犬病传入日本表示担忧。最近,在2024年2月,群马县的一只狗咬伤了几个人,但没有按照《狂犬病防治法》的要求接种疫苗,人们对狂犬病及其发生的风险表示强烈关注。本文以近年来引起广泛关注的狂犬病为研究对象,阐述了狂犬病的性质。我们还概述了日本和其他国家狂犬病控制和医疗的现状,并讨论了未来的问题。
{"title":"[Current situations and future issues surrounding rabies in Japan and other countries].","authors":"Naoto Ito, Akira Nishizono","doi":"10.2222/jsv.74.1","DOIUrl":"10.2222/jsv.74.1","url":null,"abstract":"<p><p>Rabies is a viral infectious disease affecting the central nervous system that is generally transmitted from mammals such as dogs. This disease is characterized by a long incubation period (a few months on average) and a high mortality rate of almost 100%. While there are highly effective rabies vaccines, no reliable treatment has been established to date. In Japan, the disease was successfully eradicated in 1957 as a result of exhaustive control measures including vaccination of dogs in accordance with the Rabies Prevention Law. Since then, Japan has continued to take rabies control measures based on this law, which are stricter than international standards. On the other hand, there have been a total of four imported human rabies cases found in Japan. The fourth imported case confirmed in Toyohashi City in May 2020 is still fresh in our minds. In April 2022, special measures were taken to quarantine dogs brought by evacuees from Ukraine to Japan, and many people expressed concern about the introduction of rabies into Japan. More recently, in February 2024, a dog that bit several people in Gunma Prefecture did not receive the shots required by the Rabies Prevention Law, and there was strong concern about rabies and the risk of its occurrence. In this article, we focus on rabies, which has recently attracted a great deal of attention, and describe the nature of this infectious disease. We also outline the current situations of rabies control and medical care in Japan and other countries and discuss the future issues.</p>","PeriodicalId":75275,"journal":{"name":"Uirusu","volume":"74 1","pages":"1-8"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142775401","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Control of infectious virus shedding through mucosal antibody response following SARS-CoV-2 infection]. [SARS-CoV-2感染后粘膜抗体反应对传染性病毒脱落的控制]。
Pub Date : 2024-01-01 DOI: 10.2222/jsv.74.29
Sho Miyamoto, Tadaki Suzuki
{"title":"[Control of infectious virus shedding through mucosal antibody response following SARS-CoV-2 infection].","authors":"Sho Miyamoto, Tadaki Suzuki","doi":"10.2222/jsv.74.29","DOIUrl":"https://doi.org/10.2222/jsv.74.29","url":null,"abstract":"","PeriodicalId":75275,"journal":{"name":"Uirusu","volume":"74 1","pages":"29-34"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142775455","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Development of human iPS cell-derived alveolar and airway models using micropatterning plate for SARS-CoV-2 research]. [利用微图板开发人类iPS细胞衍生的肺泡和气道模型用于SARS-CoV-2研究]。
Pub Date : 2024-01-01 DOI: 10.2222/jsv.74.35
Rina Hashimoto, Atsushi Masui, Shimpei Gotoh, Kazuo Takayama

Advanced cell culture systems including human induced pluripotent stem (iPS) cells and organoids enable the generation of intricate structural and functional organ models in vitro. Application of these advanced cell culture systems to research on a wide range of diseases including infectious diseases is underway. Due to the impact of the coronavirus disease 2019 (COVID-19) pandemic, advanced cell culture systems in the virus research field are rapidly becoming popular. Respiratory models generated using human iPS cells and organoid technology are useful for analyzing respiratory cell responses caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. However, there is still room for the development of an apical-out model, which is essential for simple virus infection experiments, and a model that can analyze host responses in the alveoli and airways. In this study, we developed human iPS cell-derived alveolar and airway models with an apical-out structure by using a micropatterning plate. In the alveolar model, we confirmed that this model contains abundant type II alveolar epithelial (AT2) cells, which are the target cells of SARS-CoV-2 in the alveoli. In the airway model, we confirmed that this model contains abundant ciliated cells, which are the target cells of SARS-CoV-2 in the airway. Using our alveolar and airway models, we can analyze the differences in infection efficiency and host response of each SARS-CoV-2 variant. We hope that the human iPS cell-derived alveolar and airway models generated using a micropatterning plate will be used to analyze not only SARS-CoV-2 but also a wide range of respiratory viruses.

包括人类诱导多能干细胞和类器官在内的先进细胞培养系统能够在体外生成复杂的结构和功能器官模型。这些先进的细胞培养系统正在应用于包括传染病在内的广泛疾病的研究中。由于2019冠状病毒病(COVID-19)大流行的影响,病毒研究领域的先进细胞培养系统迅速受到欢迎。利用人类iPS细胞和类器官技术生成的呼吸道模型可用于分析由严重急性呼吸综合征冠状病毒2 (SARS-CoV-2)感染引起的呼吸道细胞反应。然而,对于简单的病毒感染实验和分析肺泡和气道中宿主反应的模型来说,仍有发展的空间。在这项研究中,我们利用微图板建立了人类iPS细胞衍生的具有尖向外结构的肺泡和气道模型。在肺泡模型中,我们证实该模型含有丰富的II型肺泡上皮细胞(AT2),这是SARS-CoV-2在肺泡中的靶细胞。在气道模型中,我们证实该模型含有丰富的纤毛细胞,纤毛细胞是SARS-CoV-2在气道中的靶细胞。利用我们的肺泡和气道模型,我们可以分析每种SARS-CoV-2变体的感染效率和宿主反应的差异。我们希望利用微图板生成的人类iPS细胞衍生的肺泡和气道模型不仅可以用于分析SARS-CoV-2,还可以用于分析各种呼吸道病毒。
{"title":"[Development of human iPS cell-derived alveolar and airway models using micropatterning plate for SARS-CoV-2 research].","authors":"Rina Hashimoto, Atsushi Masui, Shimpei Gotoh, Kazuo Takayama","doi":"10.2222/jsv.74.35","DOIUrl":"10.2222/jsv.74.35","url":null,"abstract":"<p><p>Advanced cell culture systems including human induced pluripotent stem (iPS) cells and organoids enable the generation of intricate structural and functional organ models in vitro. Application of these advanced cell culture systems to research on a wide range of diseases including infectious diseases is underway. Due to the impact of the coronavirus disease 2019 (COVID-19) pandemic, advanced cell culture systems in the virus research field are rapidly becoming popular. Respiratory models generated using human iPS cells and organoid technology are useful for analyzing respiratory cell responses caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. However, there is still room for the development of an apical-out model, which is essential for simple virus infection experiments, and a model that can analyze host responses in the alveoli and airways. In this study, we developed human iPS cell-derived alveolar and airway models with an apical-out structure by using a micropatterning plate. In the alveolar model, we confirmed that this model contains abundant type II alveolar epithelial (AT2) cells, which are the target cells of SARS-CoV-2 in the alveoli. In the airway model, we confirmed that this model contains abundant ciliated cells, which are the target cells of SARS-CoV-2 in the airway. Using our alveolar and airway models, we can analyze the differences in infection efficiency and host response of each SARS-CoV-2 variant. We hope that the human iPS cell-derived alveolar and airway models generated using a micropatterning plate will be used to analyze not only SARS-CoV-2 but also a wide range of respiratory viruses.</p>","PeriodicalId":75275,"journal":{"name":"Uirusu","volume":"74 1","pages":"35-44"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142775504","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Data-Driven Research for Understanding and Predicting Viral Epidemics and Evolution]. [了解和预测病毒流行和进化的数据驱动研究]。
Pub Date : 2024-01-01 DOI: 10.2222/jsv.74.49
Jumpei Ito

The era of big data has begun in life sciences, and virology is no exception. Especially since COVID-19, virology has become one of the most genome data-rich fields in life sciences. In this article, I will introduce the new paradigm of "understanding and predicting viral epidemics and evolution, " made possible by the emergence of vast amounts of genome data, focusing on my research to date. Additionally, I would like to introduce our efforts toward advancing the field of viral informatics.

大数据时代已经在生命科学领域开启,病毒学也不例外。特别是自2019冠状病毒病以来,病毒学已成为生命科学中基因组数据最丰富的领域之一。在本文中,我将介绍“理解和预测病毒流行和进化”的新范式,这是由于大量基因组数据的出现而成为可能的,并将重点放在我迄今为止的研究上。此外,我想介绍我们为推进病毒信息学领域所做的努力。
{"title":"[Data-Driven Research for Understanding and Predicting Viral Epidemics and Evolution].","authors":"Jumpei Ito","doi":"10.2222/jsv.74.49","DOIUrl":"10.2222/jsv.74.49","url":null,"abstract":"<p><p>The era of big data has begun in life sciences, and virology is no exception. Especially since COVID-19, virology has become one of the most genome data-rich fields in life sciences. In this article, I will introduce the new paradigm of \"understanding and predicting viral epidemics and evolution, \" made possible by the emergence of vast amounts of genome data, focusing on my research to date. Additionally, I would like to introduce our efforts toward advancing the field of viral informatics.</p>","PeriodicalId":75275,"journal":{"name":"Uirusu","volume":"74 1","pages":"49-56"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142775406","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Analysis of RNA virus pathogenicity and development of novel prevention methods.] RNA病毒致病性分析及新型预防方法的发展
Pub Date : 2024-01-01 DOI: 10.2222/jsv.74.57
Ryuta Uraki

In the first quarter of the 21st century, infectious diseases caused by RNA viruses such as SARS, pandemic influenza viruses, MERS, Zika virus, and SARS-CoV-2 have spread. When such emerging and re-emerging viruses occur and spread, it is important for public health to quickly analyze the characteristics of these viruses and develop preventive measures. We found that the Zika virus causes damage to the testes, leading to testicular atrophy; that a vaccine based on mosquito salivary gland proteins suppresses mosquito-borne Zika virus transmission/infection; that the pathogenicity of SARS-CoV-2 Omicron variants BA.2, BA.4, and BA.5 isolated from patients is comparable to that of Omicron BA.1; and that a strategy targeting regulatory T cells to enhance vaccine efficacy is effective. Here, I would like to briefly discuss these findings.

21世纪头25年,SARS、大流行性流感病毒、MERS、寨卡病毒、SARS- cov -2等RNA病毒引发的传染病相继蔓延。当这些新出现和再出现的病毒发生和传播时,快速分析这些病毒的特征并制定预防措施对公共卫生至关重要。我们发现寨卡病毒会对睾丸造成损伤,导致睾丸萎缩;基于蚊子唾液腺蛋白的疫苗抑制蚊媒寨卡病毒传播/感染;从患者身上分离出的SARS-CoV-2组克隆ba2、ba4和ba5的致病性与组克隆ba1相当;并且针对调节性T细胞的策略能够有效地提高疫苗的效力。在这里,我想简要讨论一下这些发现。
{"title":"[Analysis of RNA virus pathogenicity and development of novel prevention methods.]","authors":"Ryuta Uraki","doi":"10.2222/jsv.74.57","DOIUrl":"10.2222/jsv.74.57","url":null,"abstract":"<p><p>In the first quarter of the 21st century, infectious diseases caused by RNA viruses such as SARS, pandemic influenza viruses, MERS, Zika virus, and SARS-CoV-2 have spread. When such emerging and re-emerging viruses occur and spread, it is important for public health to quickly analyze the characteristics of these viruses and develop preventive measures. We found that the Zika virus causes damage to the testes, leading to testicular atrophy; that a vaccine based on mosquito salivary gland proteins suppresses mosquito-borne Zika virus transmission/infection; that the pathogenicity of SARS-CoV-2 Omicron variants BA.2, BA.4, and BA.5 isolated from patients is comparable to that of Omicron BA.1; and that a strategy targeting regulatory T cells to enhance vaccine efficacy is effective. Here, I would like to briefly discuss these findings.</p>","PeriodicalId":75275,"journal":{"name":"Uirusu","volume":"74 1","pages":"57-66"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142775369","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pub Date : 2023-01-01 DOI: 10.2222/jsv.73.45
{"title":"","authors":"","doi":"10.2222/jsv.73.45","DOIUrl":"https://doi.org/10.2222/jsv.73.45","url":null,"abstract":"","PeriodicalId":75275,"journal":{"name":"Uirusu","volume":"73 1","pages":"45-48"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142334066","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Uirusu
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1